key: cord-0690340-d9hc7721
authors: Aliee, Hananeh; Massip, Florian; Qi, Cancan; Stella de Biase, Maria; van Nijnatten, Jos; Kersten, Elin T. G.; Kermani, Nazanin Z.; Khuder, Basil; Vonk, Judith M.; Vermeulen, Roel C. H.; Neighbors, Margaret; Tew, Gaik W.; Grimbaldeston, Michele A.; ten Hacken, Nick H. T.; Hu, Sile; Guo, Yike; Zhang, Xiaoyu; Sun, Kai; Hiemstra, Pieter S.; Ponder, Bruce A.; Mäkelä, Mika J.; Malmström, Kristiina; Rintoul, Robert C; Reyfman, Paul A.; Theis, Fabian J.; Brandsma, Corry‐Anke; Adcock, Ian M.; Timens, Wim; Xu, Cheng‐Jian; van den Berge, Maarten; Schwarz, Roland F.; Koppelman, Gerard H.; Nawijn, M.C.; Faiz, Alen
title: Determinants of expression of SARS‐CoV‐2 entry‐related genes in upper and lower airways
date: 2021-11-03
journal: Allergy
DOI: 10.1111/all.15152
sha: cee6177ee8926623ac99411e9a59ef8a53e33ad6
doc_id: 690340
cord_uid: d9hc7721

nan

To the Editor, We assessed the gene expression of SARS-CoV-2 receptors and activating proteases, and their regulation by smoking, inhaledcorticosteroids (ICS), genetics/epigenetics using nasal and bronchial samples from nine independent cohorts (see extended methods, Table S1 ).

SARS-CoV-2 cell entry factor (SCEF) genes have higher expression levels in nose than bronchi in matched samples across two cohorts ( Figure 1A -D, Table S2 ), mirroring results from previous smaller studies. 1, 2 Smoking was associated with higher expression of ACE2, TMPRSS2, FURIN, and BSG in bronchial brushes, supporting a recent meta-analysis, 3 but not in nasal brushes ( Figure 1E ,F). In contrast, smoking was associated with lower expression of CTSL in nasal and bronchial brushings (Table S3 ). The impact of smoking on the expression of ACE2 and BSG gene expression differs significantly between these tissues (Table S4) . None of these genes were associated with sex or age. Cell-type deconvolution of RNA-seq data revealed that all SCEF genes strongly correlated with predicted secretory cell proportions across tissues ( Figure 1G -I), in particular ACE2 ( Figure 1J ), in line with recent scRNA-seq data. 3, 4 We observed higher proportions of secretory cells (goblet & club cells) in bronchial samples from current smokers compared to ex/never-smokers, which was not ob- (Table S5 ). In lower airways, higher levels of ACE2 and TMPRSS2 were identified in current versus never/ex-smokers, whereas smoking was associated with higher FURIN and BSG levels in brushed cells only (Figure 2A -F, Table S6 ). Acute smoke exposure (n = 63) and secondhand smoking (infants of parents who smoked n = 9 or did not smoke, n = 13) were found to associate with higher ACE2 expression ( Figure 2G ,H, Table   S7 and S8).

No studies have investigated the longitudinal effects of ICS on SCEF genes in paired biopsies. 5, 6 In steroid-naive COPD patients, 6 months ICS ± LABA treatment decreased ACE2 expression (p = 0.009, Figure 2I , Table S9) Table S10 ).

We next investigated whether DNA-methylation is associated with SCEF expression. In pediatric nasal samples (PIAMA; n = 245), we identified eQTMs for CTSL, BSG, NRP1, FURIN, and TMPRSS2 expression (Table S11) . Bronchial eQTMs were analyzed in an adult cohort (INDURAIN; n = 169). We identified 143 eQTMs for the different SCEF genes ( Figure 2J , Table S12 ). The nasal eQTMs were influenced by age and sex, but not smoking (Table S13) , whereas bronchial eQTMs for TMPRSS2 were associated with smoking and age (Table S14) . ACE2 expression in bronchial biopsies was associated with 6 CpG sites, two of which were in the promoter region of the adjacent TMEM27 gene. ACE2 and TMEM27 expression was correlated ( Figure 2K .L) and both associated with methylation of cg20473453 ( Figure 2M ), indicating possible co-regulation of ACE2 and TMEM27.

In conclusion, although SCEF genes are more highly expressed in upper airways, first and secondhand smoke exposure only appears to influence the expression of these genes in the lower airways. CpG methylation, but not genetic variation, was associated

This is an open access article under the terms of the Creat ive Commo ns Attri bution-NonCo mmercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. 

SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication

Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids